International consortium puts nearly $2 billion into patient data behind disease models
YvesMulkers · x · 2026-10-09
An international consortium has committed nearly $2 billion to the patient data underlying disease models — funding data infrastructure rather than the AI models themselves, underscoring how critical high-quality medical data is to AI-driven drug development.
More from Venture
- When compute debt outpaces user cash: margins flow from software to physical asset owners — LexSokolin · 2026-10-09
- NeurIPS Paper Releases Market-1T, a ~1 Trillion-Observation Financial Dataset — randall_balestr · 2026-10-09
- Contra's Creative Intelligence 2026 report: AI-powered creative project sizes jump 40%+ — heyshrutimishra · 2026-10-09
- LMArena Scales From 5 to 20 as It Continues a16z Partnership — arena · 2026-10-09
- Mortgage AI startup Vesta raises Series B, revenue up 12x in a year — kimberlywtan · 2026-10-09
- FT report that hit AI stocks traced to OpenAI pitch deck amid $30B raise — Kr00ney · 2026-10-09